Optiscan Imaging (ASX:OIL) has unveiled its next generation microscopic medical imaging device known as InForm, specifically designed to transform pathology workflows by delivering real-time digital insights at point of contact with a tissue sample.
🔹Improves efficiency and accuracy of analysis and diagnosis across all pathology workflows.
🔹Expands Optiscan’s product portfolio into the pathology market, marking a pivotal milestone in advancing the company’s strategic objectives.
🔹Enhances the entire pathology workflow across a range of settings, enabling efficiencies and on-the-spot digital decision making for pathologists to improve diagnostic capabilities.
“The reveal of our revolutionary InForm™ device, the latest addition to our ever-expanding suite of hardware products, represents a significant advancement in the evolution of digital pathology. InForm™ has the ability to enhance the entire pathology workflow from bedside to laboratory and beyond, by improving the speed, accuracy and flexibility of testing, analysis and diagnosis.” – Optiscan CEO and Managing Director, Dr Camile Farah
ASX announcement ⚡ https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02914499-3A661919